Table 4.
SDOCT studies in premature neonates undergoing ROP screening
| Maldonado et al33 | Vinekar et al17 | |
|---|---|---|
| Study Patient Characteristics | ||
| Number of patients | 42 | 74 |
| Body weight (g) | 760 (488–1032) | 1282 |
| Gestational age (wk PMA) | 26 (25–27) | 31 (30–33) |
| ROP stage | 0–3 | 0–2 |
| Plus | 5 | NR |
| Laser | 12 | 0 |
| Race | ||
| White | 17 (40.5) | 0 |
| African American | 22 (52.4) | 0 |
| Asian | 0 | 0 |
| Hispanic | 3 (7.1) | 0 |
| Indian | 0 | 74 (100) |
| Age at Imaging (wk) | ||
| Earliest imaging | 30 | 35 |
| Latest follow-up | 43 | 52 |
| MEOP, n (%) | ||
| CME | 21 (50) | 12 (16)a |
| CFT | 166 (91–449) | 206 (108–304) |
| CME Characteristics | ||
| Bilateral CME | 21 | NR |
| Bulging fovea | 13 (62) | 11 (47) |
| CME Resolution | ||
| CME earliest resolution | 36 | NE |
| CME latest resolution | 43 | 52 |
Abbreviations: CME, cystoid macular edema; NR, not reported.
a
23 eyes from a total of 146 eyes with ROP stages 0–2.